Zoetis announces retirement of rob polzer at the end of 2025 and the appointment of kevin esch as president of research & development for world leader in animal health beginning in 2026

Parsippany, n.j.--(business wire)---- $zts #animalhealth--zoetis inc. (nyse: zts) today announced that following a 10-year distinguished career dedicated to advancing veterinary medicine and innovation, rob polzer, ph.d., executive vice president and president, research and development, has made the personal decision to retire at the end of 2025. after a planful succession process, zoetis has appointed kevin esch, d.v.m, m.p.h., ph.d., dipl. acvp (anatomic) to succeed dr. polzer in this role, effective january 1, 202.
ZTS Ratings Summary
ZTS Quant Ranking